Results 251 to 260 of about 1,908,615 (320)

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Reducing low-dose exposure in helical TomoTherapy for locally advanced left-sided breast cancer with a deformable image registration-based dose-mimicking workflow. [PDF]

J Appl Clin Med Phys
Chang CC, Tsai JT, Hsu SM.
europepmc   +1 more source

Porous Organic Frameworks‐Based Nanomaterials in Colorectal Cancer Therapy: From Drug Delivery to Personalized Nano‐Vaccine

Cancer Nexus, EarlyView.
ABSTRACT Colorectal cancer (CRC), as the second most common cause of cancer death worldwide, has seen a significant increase in its incidence rate in recent years. However, the current major clinical treatment methods, such as surgery, chemotherapy and radiotherapy, still have certain limitations and are difficult to achieve a complete cure.
Xiaoyu Song, Hao Zhang, Yinghui Wang, Chao Luo   +3 more
wiley   +1 more source

Experimental evaluation of silicon carbide P-N detectors under thermal and fast neutron irradiation at the RA-6 nuclear research reactor. [PDF]

Sci Rep
Pérez M, Blostein JJ, Zamorano F, Fleta C, Marín J, Pellegrini G, Guardiola C.   +6 more
europepmc   +1 more source

Mechanisms of Resistance to Cancer Immunotherapy: A Host–Tumor Interaction Perspective; A Review Article

Cancer Nexus, EarlyView.
Mechanisms of resistance to cancer immunotherapy from a host–tumor interaction perspective. The central tumor cell is protected by multiple resistance mechanisms, including genetic mutations, epigenetic modifications, and metabolic alterations. The immunosuppressive tumor microenvironment features myeloid‐derived suppressor cells (MDSCs), regulatory T ...
Mohammed Elmujtba Adam Essa, Hamid Noori, Abdelkareem A. Ahmed   +2 more
wiley   +1 more source

Combining Statins with Radiotherapy for Prostate Cancer: From Photon Experience to Proton Potential. [PDF]

J Clin Med
Saki M, Artz ME, Park J, Johnson PB, Bryant C, Balaji KC, Grewal H.   +6 more
europepmc   +1 more source

Micropatterned Scintillator Films With Engineered Cs3Cu2I5/CsCu2I3 Nanocrystals for Low‐Crosstalk X‐Ray Imaging at Clinically Relevant Tube Voltage

ENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
Polyethylene glycol‐coated, lead‐free CsCu2I3 nanocrystal scintillator films achieve superior X‐ray imaging resolution over unpatterned films at 80 kVp by reducing crosstalk through lithographic micropatterning and optimized thickness control. The spatial resolution of X‐ray imaging is often limited by radioluminescence scattering, which is exacerbated
Atanu Jana, Sunjung Park, Deblina Das, Sourav Mal, Seoyoung Kwak, Sungwoo Kim, Sangeun Cho   +6 more
wiley   +1 more source

Can Advances in Artificial Intelligence Strengthen the Role of Intraoperative Radiotherapy in the Treatment of Cancer? [PDF]

Cancers (Basel)
Krengli M, Kruszyna-Mochalska MM, Pasqualetti F, Malicki J.   +3 more
europepmc   +1 more source

Synchrotron‐generated microbeams as a radiosurgical alternative for drug‐resistant epilepsies: Proof of concept in a mouse model of mesiotemporal lobe epilepsy

Epilepsia, EarlyView.
Abstract Objective One‐third of patients with epilepsy, particularly those with mesial temporal lobe epilepsy (MTLE), remain resistant to medication. Resective surgery, the gold standard, is highly invasive and carries significant risks. Here, using a mouse model, we explored the potential of microbeam radiation therapy (MRT), a new technique based on ...
Loan Samalens, Camille Beets, Clothilde Courivaud, Sarvenaz Keshmiri, Jean‐François Adam, Paolo Pellicioli, Emmanuel Luc Barbier, Raphaël Serduc, Antoine Depaulis   +8 more
wiley   +1 more source

Can ADC changes help mRECIST or LI-RADS treatment response algorithm better diagnose pathological response of HCC after preoperative radiotherapy? Secondary analysis of a prospective phase 2 trial. [PDF]

Insights Imaging
Cong R, Wu F, Zhai Y, Ye F, Wang S, Chen Z, Feng B, Wang L, Zhu Y, Wang S, Zhao X, Chen B, Ma X.   +12 more
europepmc   +1 more source